ACCA Strategic Professional · Strategic Business Leader · Financial analysis and decision-making techniques
Zorlu Components is choosing between three product launches. The board has no reliable way to estimate the probability of each market outcome, and the directors are cautious and want to avoid the worst possible result. Which decision criterion best fits this approach, and what does it imply?
Maximin fits. Because probabilities cannot be estimated and the directors are cautious, they should compare the worst payoff of each launch and choose the launch whose worst outcome is best. This protects against the worst result, unlike maximax, which is optimistic, or expected value, which requires probabilities.
- AMaximin: choose the option whose worst possible payoff is the highestCorrect
- BMaximax: choose the option with the highest possible payoff in the best outcome
- CExpected value: choose the option with the highest probability-weighted payoff
- DMinimax regret: choose the option with the highest best-case payoff
Explanation
Maximin suits risk-averse decision makers when probabilities are unknown, because it ranks options by their worst payoff and picks the best of those. Maximax is the optimist's rule. Expected value needs probabilities, which are not available here. Minimax regret minimises the largest opportunity loss, not best-case payoff.
Did you get it right without looking?
One question tells you little. A timed set on Financial analysis and decision-making techniques shows your real accuracy, how long you take and where you lose marks.
More Financial analysis and decision-making techniques questions
- Zentra Foods, a listed manufacturer, has a share price that has risen steadily while its earnings per share have stagnated. The board wants …
- Verano Group's board is judging its manager of the Asia division using only division ROCE, which has risen from 14% to 19%. The manager achi…
- Delmar Corp's chief executive is rewarded on annual accounting profit. She proposes cutting research and training spending, which will lift …
- Orlan plc's board plans to boost the share price by cutting research spending sharply for two years, which will lift reported profit immedia…
- Marlow Pharma is considering a project costing $300,000 now. It is expected to generate net cash inflows of $120,000 at the end of each of y…
- Ardent Retail has gearing (debt/equity) of 150% and interest cover of 2.0 times. Its sector peers average gearing of 60% and interest cover …